Yüklüyor......
Erythropoiesis lagging? pIgA1 steps in to assist Epo
Although erythropoietin (Epo) is commonly used as a therapy for anemia, recent studies have suggested that Epo therapy is associated with adverse outcomes. A new study shows that polymeric IgA1 positively regulates erythropoiesis through binding to transferrin receptor 1 (Tfr1), suggesting new thera...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3339494/ https://ncbi.nlm.nih.gov/pubmed/22064409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.2501 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|